Otenabant

Otenabant
Systematic (IUPAC) name
1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4- carboxamide
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 686344-29-6 YesY
ATC code None
UNII J8211Y53EF N
KEGG D09362 YesY
ChEMBL CHEMBL562668 N
Chemical data
Formula C25H25Cl2N7O 
Mol. mass 510.4
 N(what is this?)  (verify)

Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB1 antagonist.[1] It was developed by Pfizer for the treatment of obesity,[2] but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.[3]

See also

  • Discovery and development of Cannabinoid Receptor 1 Antagonists

References